FreeRx
Artemether + Lumefantrine Tablets
Artemether 20 mg + Lumefantrine 120 mg
Target markets: Africa, SE Asia
FormulationsFreely Exportable
HRZE Fixed-Dose Combination Tablets
Isoniazid + Rifampicin + Pyrazinamide + Ethambutol
WHO-GMP Partner-Manufactured
Target: Africa, SE Asia
Regulatory-Aware Support
Reliable Supply Chain
Product Overview
The WHO-recommended first-line fixed-dose combination for the intensive phase of tuberculosis treatment. Supplied to national TB programmes and Global Fund / Stop TB Partnership tenders through WHO-GMP certified manufacturing partners.
Key Points
- WHO-recommended first-line TB fixed-dose combination
- Core Global Fund and Stop TB Partnership tender product
- Paediatric dispersible FDCs available on request
Quick Specifications
| Generic Name | Isoniazid + Rifampicin + Pyrazinamide + Ethambutol |
|---|---|
| Dosage Form | Tablet (fixed-dose combination) |
| Strength | 75 mg / 150 mg / 400 mg / 275 mg |
| HS Code | 3004.90 |
| Packaging | Blister packs, institutional/programme bulk packs |
| MOQ | MOQ on request — tender quantities supported |
| Shelf Life | 24 months, batch-dependent |
| Storage | Store below 30°C, protect from moisture |
Regulatory Information
Schedule H — Prescription Only
Schedule H — institutional and tender supply. WHO Prequalification status confirmed per manufacturing partner.
View Anti-Tuberculosis class detailsRequirements vary by destination. Verify current requirements with the relevant authority before shipment. See our Compliance page.
Request a Quote
Get pricing, MOQ and export details for HRZE Fixed-Dose Combination Tablets.
Need documentation first?
Our team can share a product brochure and manufacturing-partner regulatory summary on request — just mention it in your enquiry.